Suboxone Film Litigation Group

Suboxone Film is an oral dissolvable medicine developed as a treatment for opioid addiction. Unfortunately, the film can cause dental erosion and decay—a danger the manufacturers did not warn users about for 10 years. The group assists AAJ members with navigating the newly formed MDL and holding manufacturers accountable for their negligent failure to warn.

Group History:

The Suboxone Film Litigation Group was formed at AAJ’s 2024 Winter Convention. The group provides members with a list server, document library, and other resources such as draft complaints, intake criteria, expert information, legal research, and discovery. This Litigation Group meets at AAJ Annual and Winter Conventions, or as needed by group members.

Membership:

Suboxone Film Litigation Group is limited to Regular, Sustaining, Life, and President's Club members.

Dues:

The Suboxone Film Litigation Group is complimentary for members of the AAJ Pharmaceutical and Medical Device Section who can agree to the terms and conditions of membership in the Litigation Group’s Affidavit. If you are not yet a member, you can join the Pharmaceutical and Medical Device Section here.

Litigation Group Cochairs:

• Alyson Beridon | Herzfeld Suetholz Gastel Leniski and Wall PLLC, Cincinnati, OH
• Erin Copeland | Fibich Leebron Copeland & Briggs, Houstin, TX
  
• Ashley Case Sletvold | Peiffer Wolf Carr Kane Conway & Wise, Cleveland, OH